Concord Drugs Ltd. - Research Center
538965 CONCORD Group (X) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 51.31 | 58.96 | 51.36 | 51.34 | 48.08 |
| Expenses | |||||
| Material consumed | 40.90 | 42.14 | 42.28 | 42.70 | 39.61 |
| Manufacturing expenses | - | - | 0.55 | 0.77 | 0.78 |
| Personnel expenses | 4.63 | 4.89 | 3.76 | 3.51 | 2.53 |
| Selling expenses | - | - | - | - | - |
| Adminstrative expenses | 1.44 | 6.34 | 1.55 | 1.02 | 1.50 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 46.97 | 53.36 | 48.14 | 47.99 | 44.42 |
| Operating profit | 4.34 | 5.59 | 3.22 | 3.34 | 3.66 |
| Other recurring income | 0.01 | 0.10 | 0.09 | 0.12 | 0.09 |
| Adjusted PBDIT | 4.35 | 5.69 | 3.31 | 3.46 | 3.74 |
| Financial expenses | 1.62 | 1.68 | 1.42 | 1.54 | 1.59 |
| Depreciation | 1.60 | 1.76 | 1.37 | 1.46 | 1.71 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 1.13 | 2.25 | 0.53 | 0.46 | 0.44 |
| Tax charges | 0.23 | 0.65 | 1.01 | 0.13 | 0.03 |
| Adjusted PAT | 0.89 | 1.59 | -0.48 | 0.33 | 0.41 |
| Non recurring items | - | - | 3.76 | - | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 0.89 | 1.59 | 3.28 | 0.33 | 0.41 |
| Earnigs before appropriation | 14.40 | 13.51 | 11.91 | 8.63 | 8.30 |
| Equity dividend | - | - | - | - | - |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | - |
| Retained earnings | 14.40 | 13.51 | 11.91 | 8.63 | 8.30 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis